Kinnate Biopharma Inc. (KNTE) NASDAQ

$9.05 -0.88 (-8.86%)

Market Cap: $397.98M

As of 05/25/22 04:00 PM EDT. Market closed.

(KNTE)

Kinnate Biopharma Inc. (KNTE) NASDAQ

$9.05 -0.88 (-8.86%)

Market Cap: $397.98M

As of 05/25/22 04:00 PM EDT. Market closed.

Kinnate is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate’s mission is to expand the reach of targeted therapeutics by developing products for underserved populations. Kinnate utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, ... read more

Kinnate is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate’s mission is to expand the reach of targeted therapeutics by developing products for underserved populations. Kinnate utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, which it refers to as the Kinnate Discovery Engine, to develop targeted therapies. Based in San Francisco and San Diego, California, the Kinnate team is composed of drug discovery experts supported by a distinguished group of scientific advisors. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
31
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$9.89
Previous Close
$9.93
Days Range
$8.73 - $10.01
52 week range
$7.29 - $26.05
Volume
185,525
Avg. Volume (30 days)
153,325
Market Cap
$397.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
43,975,487
Open
$9.89
Previous Close
$9.93
Days Range
$8.73 - $10.01
52 week range
$7.29 - $26.05
Volume
185,525
Avg. Volume (30 days)
153,325
Market Cap
$397.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
43,975,487

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KINNATE BIOPHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Williams Richard Thomas Chief Medical Officer Mar 14, 2022 Buy $8.37 25,000 209,250 42,333 Mar 15, 2022, 05:01 PM
Williams Richard Thomas Chief Medical Officer Mar 11, 2022 Buy $8.64 15,000 129,600 17,333 Mar 15, 2022, 05:01 PM
GORDON CARL L Director Feb 15, 2022 Buy $9.96 9,000 89,640 3,509,030 Feb 15, 2022, 09:51 PM
GORDON CARL L Director Feb 14, 2022 Buy $9.95 30,700 305,486 3,500,030 Feb 15, 2022, 09:51 PM
GORDON CARL L Director Feb 11, 2022 Buy $10.22 156,000 1,594,320 3,469,330 Feb 15, 2022, 09:51 PM
ORBIMED ADVISORS LLC Director Feb 11, 2022 Buy $10.22 156,000 1,594,320 3,469,330 Feb 15, 2022, 09:42 PM
ORBIMED ADVISORS LLC Director Feb 15, 2022 Buy $9.96 9,000 89,640 3,509,030 Feb 15, 2022, 09:42 PM
ORBIMED ADVISORS LLC Director Feb 14, 2022 Buy $9.95 30,700 305,486 3,500,030 Feb 15, 2022, 09:42 PM
Tananbaum James B. Director Dec 03, 2020 Buy $20.00 1,000,000 20,000,000 500,000 Dec 04, 2020, 09:39 PM
Foresite Capital Management IV, LLC 10% Owner Dec 03, 2020 Option Exercise $20.00 1,000,000 20,000,000 500,000 Dec 04, 2020, 08:57 PM
ORBIMED ADVISORS LLC Director Dec 02, 2020 Buy $20.00 750,000 15,000,000 450,000 Dec 04, 2020, 06:11 PM
GORDON CARL L Director Dec 02, 2020 Buy $20.00 750,000 15,000,000 450,000 Dec 04, 2020, 05:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Williams Richard Thomas Chief Medical Officer 03/14/2022 209,250
Williams Richard Thomas Chief Medical Officer 03/11/2022 129,600
GORDON CARL L Director 02/15/2022 89,640
GORDON CARL L Director 02/14/2022 305,486
GORDON CARL L Director 02/11/2022 1,594,320
ORBIMED ADVISORS LLC Director 02/11/2022 1,594,320
ORBIMED ADVISORS LLC Director 02/15/2022 89,640
ORBIMED ADVISORS LLC Director 02/14/2022 305,486
Tananbaum James B. Director 12/03/2020 20,000,000
Foresite Capital Management IV, LLC 10% Owner 12/03/2020 20,000,000
ORBIMED ADVISORS LLC Director 12/02/2020 15,000,000
GORDON CARL L Director 12/02/2020 15,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
0.22%
2Q
12/31/2021
03/31/2021
0.28%
3Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.22%
2Q
03/31/2021
0.28%
3Q